Søvik E, Kløw N-E, Brekke M, Stavnes S
Department of Cardiovascular Radiology, Heart and Lung Center, Ulleval University Hospital, Oslo, Norway.
Acta Radiol. 2003 May;44(3):294-301. doi: 10.1080/j.1600-0455.2003.00059.x.
To study the feasibility of placing a polytetrafluoroethylene (PTFE)-covered stent graft into native coronary arteries and assess the complications and the restenosis rate.
Fifty consecutive patients with stable angina pectoris were included and the stent graft was placed into native coronary arteries. Clinical and angiographic follow-up were performed after 6 months.
The stent grafts were successfully placed in all patients. The mean reference diameter was 3.3 +/- 0.6 mm. During follow-up the stent grafts occluded in patients after 1, 2 and 2.5 months and one more was occluded at 6 months. Three patients experienced myocardial infarction, 2 Q wave and one non-Q wave. After 6 months 42 (84%) patients had angina NYHA class 0 or 1. Target vessel revascularization was done in 11 cases for restenosis in the graft (n = 4), outside the graft (n = 3) and both (n = 4), giving a restenosis rate of 24%. The total major adverse coronary events at 6 months was 24%.
The stent graft was deployed with a high success rate. The restenosis rate was not higher than expected for bare stents. However, this study showed that subacute occlusion may occur more frequently and we therefore recommend that ticlopidine or clopidogrel treatment should be prolonged to at least 3 months.
研究将聚四氟乙烯(PTFE)覆膜支架移植物置入冠状动脉原位的可行性,并评估并发症和再狭窄率。
纳入50例连续性稳定型心绞痛患者,将支架移植物置入冠状动脉原位。6个月后进行临床和血管造影随访。
所有患者的支架移植物均成功置入。平均参考直径为3.3±0.6mm。随访期间,支架移植物分别在1个月、2个月和2.5个月时发生闭塞,另有1例在6个月时闭塞。3例患者发生心肌梗死,2例为Q波心肌梗死,1例为非Q波心肌梗死。6个月后,42例(84%)患者的心绞痛为纽约心脏协会(NYHA)0级或1级。11例患者因移植物内再狭窄(n = 4)、移植物外再狭窄(n = 3)或两者均有(n = 4)而进行了靶血管血运重建,再狭窄率为24%。6个月时总的主要不良冠状动脉事件发生率为24%。
支架移植物的置入成功率高。再狭窄率不高于裸支架预期。然而,本研究表明亚急性闭塞可能更频繁发生,因此我们建议噻氯匹定或氯吡格雷治疗应延长至至少3个月。